Trevi Therapeutics
TRVI
#6408
Rank
A$0.94 B
Marketcap
$9.80
Share price
-1.11%
Change (1 day)
97.58%
Change (1 year)

Earnings for Trevi Therapeutics (TRVI)

Earnings in 2024 (TTM): -A$72.72 Million

According to Trevi Therapeutics's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$45.29 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Trevi Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -A$75.63 Million67%
2023 -A$45.29 Million2.43%
2022 -A$44.21 Million-14.45%
2021 -A$51.68 Million1.36%
2020 -A$50.99 Million23.64%
2019 -A$41.24 Million27.54%
2018 -A$32.34 Million